Trial Profile
A comparison of duloxetine hydrochloride, venlafaxine extended release, and placebo in the treatment of generalized anxiety disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Venlafaxine
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly and Company (India) Pvt. Ltd
- 13 Nov 2005 New trial record.